PPT-Cardiometabolic Risk: Diabetes Management

David J Albrecht DO Heart amp Vascular 2018 Winter Conference Cardiovascular risk m odification in relation to current diabetes management therapies Case study highlighting the therapeutic decisions . People with diabetes have high blood glucose also called high blood sugar or hyperglycemia Diabetes is a disorder of metabolism the way the body uses digested food for energy The digestive tract breaks down carbohydratessugars and starches found in 1. AACE Comprehensive Care Plan. 2. Handelsman Y, et al. . Endocr Pract. . 2011;17(suppl 2):1-53.. Glycemic Management in Type 2 Diabetes. Therapeutic Lifestyle Change. 3. Components of Therapeutic Lifestyle Change. Prof. John Betteridge, MD. University College London. London, United Kingdom. Cardio. Diabetes . Master. . Class. Asian. . chapter. January. 28-30 2011, . Shanghai. Slide lecture prepared and held by:. Dr. Shenaz Seedat. Endocrinologist. Greenslopes. Private Hospital. Outline. The physiology of fasting. Risks associated with fasting. Management – general considerations. Management of fasting in type 1 diabetes mellitus. Chapter 5. Thomas . Ransom, Ronald Goldenberg, Amanda . Mikalachki. , Ally . PH . Prebtani. , . Zubin. . Punthakee. Canadian Diabetes Association 2013 Clinical Practice Guidelines. Key Points. At this time, there are no safe and effective strategies to prevent T1DM. Applying evidence based medicine to clinical care. Cardiovascular disease is the biggest killer in UK. Number. of . deaths. (000’s). 124,037. 60,666. 18,165. 33,634. 16,216. 12,762. 103,431. 19,996. A lifetime risk challenge. Priorities in the management . of . type 2 diabetes:. Past, present and future. Sir George Alberti, MD. Diabetes UK Chairman. Newcastle. , United Kingdom. Cardio. Diabetes . 1. Obesity. Management of Common Comorbidities in Diabetes. 2. 3. 4. More Than Two Thirds of US Adults Are Overweight or Obese. 5. *2014 rate of overweight not reported in . Flegal. et al 2016; 2012 rate carried over based on historic stability of overweight prevalence.. Rashmi Kudesia, . M.D. M.Sc.. Icahn School of Medicine at Mount . Sinai. November . 18, 2015. Objectives. To highlight the dilemmas in PCOS management in the . primary . care . setting. To address barriers . ” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care.. Maternal Child and Reproductive Health Fellow . September 7, 2016. Disclosures. I have nothing to disclose . Objectives. At the end of this lecture, you should be able to: . Define gestational diabetes, overt diabetes of pregnancy, diabetes mellitus type II . risk factors in . peri. -urban adolescent school learners in . mthatha. , South Africa. . Presented . by. BN Nkeh-Chungag. Cardiometabolic. risk factors in adolescents. There is no universal consensus on the definition of . Prof Kausik Ray, . BSc (. hons. ), . MBChB. , MRCP, MD, MPhil (. Cantab. ), FACC, FESC, FAHA. Professor of Cardiovascular Disease Prevention. St Georges University of London. Honorary Consultant Cardiologist St Georges Hospital. Nathan D. Wong, PhD, FACC, FAHA, FNLA, FASPC. Professor and Director. Heart Disease Prevention Program. Division of Cardiology. University of California, Irvine. Editorial Lead, ACC Diabetes and Cardiometabolic Clinical Topic Collection.